Response Category, n (%) | Eribulin/S-1 (n = 30) |
---|---|
Objective Response Rate; 95%CI | 10 (33.3); 17.3–52.8 |
Complete Response | 1 (3.3) |
Partial Response | 9 (30) |
Stable Disease | 12 (40) |
Progressive Disease | 7 (23.3) |
Clinical Benefit Rate; 95%CI | 13 (43.3); 25.5–62.6 |
Disease Control Rate; 95%CI | 22 (73.3); 54.1–87.7 |